BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 36916064)

  • 1. The use of Nicotinamide and Nicotinamide riboside as an adjunct therapy in the treatment of glaucoma.
    Goulart Nacácio E Silva S; Occhiutto ML; Costa VP
    Eur J Ophthalmol; 2023 Sep; 33(5):1801-1815. PubMed ID: 36916064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glaucoma as a Metabolic Optic Neuropathy: Making the Case for Nicotinamide Treatment in Glaucoma.
    Williams PA; Harder JM; John SWM
    J Glaucoma; 2017 Dec; 26(12):1161-1168. PubMed ID: 28858158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotinamide riboside as a neuroprotective therapy for glaucoma: study protocol for a randomized, double-blind, placebo-control trial.
    Leung CKS; Ren ST; Chan PPM; Wan KHN; Kam AKW; Lai GWK; Chiu VSM; Ko MWL; Yiu CKF; Yu MCY
    Trials; 2022 Jan; 23(1):45. PubMed ID: 35039056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of NAD
    Pietris J
    J Nutr Sci Vitaminol (Tokyo); 2022; 68(3):151-154. PubMed ID: 35768245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Narrative Review of Nicotinamide Adenine Dinucleotide (NAD)+ Intermediates Nicotinamide Riboside and Nicotinamide Mononucleotide for Keratinocyte Carcinoma Risk Reduction.
    Kahn B; Borrelli M; Libby T
    J Drugs Dermatol; 2022 Oct; 21(10):1129-1132. PubMed ID: 36219044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Balancing NAD
    Cercillieux A; Ciarlo E; Canto C
    Cell Mol Life Sci; 2022 Aug; 79(8):463. PubMed ID: 35918544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevation of NAD
    Metcalfe M; David BT; Langley BC; Hill CE
    Exp Neurol; 2023 Oct; 368():114479. PubMed ID: 37454712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Equilibrative Nucleoside Transporters Mediate the Import of Nicotinamide Riboside and Nicotinic Acid Riboside into Human Cells.
    Kropotov A; Kulikova V; Nerinovski K; Yakimov A; Svetlova M; Solovjeva L; Sudnitsyna J; Migaud ME; Khodorkovskiy M; Ziegler M; Nikiforov A
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic Treatment with Nicotinamide Riboside Is Protective in Two Mouse Models of Retinal Ganglion Cell Damage.
    Zhang X; Zhang N; Chrenek MA; Girardot PE; Wang J; Sellers JT; Geisert EE; Brenner C; Nickerson JM; Boatright JH; Li Y
    Pharmaceutics; 2021 Jun; 13(6):. PubMed ID: 34208613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Purine nucleoside phosphorylase controls nicotinamide riboside metabolism in mammalian cells.
    Kropotov A; Kulikova V; Solovjeva L; Yakimov A; Nerinovski K; Svetlova M; Sudnitsyna J; Plusnina A; Antipova M; Khodorkovskiy M; Migaud ME; Gambaryan S; Ziegler M; Nikiforov A
    J Biol Chem; 2022 Dec; 298(12):102615. PubMed ID: 36265580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotinamide, Nicotinamide Riboside and Nicotinic Acid-Emerging Roles in Replicative and Chronological Aging in Yeast.
    Orlandi I; Alberghina L; Vai M
    Biomolecules; 2020 Apr; 10(4):. PubMed ID: 32326437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nicotinamide riboside and caffeine partially restore diminished NAD availability but not altered energy metabolism in Alzheimer's disease.
    Ryu WI; Shen M; Lee Y; Healy RA; Bormann MK; Cohen BM; Sonntag KC
    Aging Cell; 2022 Jul; 21(7):e13658. PubMed ID: 35730144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotection in Glaucoma: NAD
    Petriti B; Williams PA; Lascaratos G; Chau KY; Garway-Heath DF
    Cells; 2021 Jun; 10(6):. PubMed ID: 34198948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Axonal Protection by Nicotinamide Riboside via SIRT1-Autophagy Pathway in TNF-Induced Optic Nerve Degeneration.
    Kitaoka Y; Sase K; Tsukahara C; Fujita N; Arizono I; Takagi H
    Mol Neurobiol; 2020 Dec; 57(12):4952-4960. PubMed ID: 32820458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging Role of Nicotinamide Riboside in Health and Diseases.
    Sharma C; Donu D; Cen Y
    Nutrients; 2022 Sep; 14(19):. PubMed ID: 36235542
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotinamide treatment robustly protects from inherited mouse glaucoma.
    Williams PA; Harder JM; Cardozo BH; Foxworth NE; John SWM
    Commun Integr Biol; 2018; 11(1):e1356956. PubMed ID: 29497468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular vesicle encapsulated nicotinamide delivered via a trans-scleral route provides retinal ganglion cell neuroprotection.
    Kim M; Kim JY; Rhim WK; Cimaglia G; Want A; Morgan JE; Williams PA; Park CG; Han DK; Rho S
    Acta Neuropathol Commun; 2024 Apr; 12(1):65. PubMed ID: 38649962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nicotinamide riboside kinases display redundancy in mediating nicotinamide mononucleotide and nicotinamide riboside metabolism in skeletal muscle cells.
    Fletcher RS; Ratajczak J; Doig CL; Oakey LA; Callingham R; Da Silva Xavier G; Garten A; Elhassan YS; Redpath P; Migaud ME; Philp A; Brenner C; Canto C; Lavery GG
    Mol Metab; 2017 Aug; 6(8):819-832. PubMed ID: 28752046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD
    Martens CR; Denman BA; Mazzo MR; Armstrong ML; Reisdorph N; McQueen MB; Chonchol M; Seals DR
    Nat Commun; 2018 Mar; 9(1):1286. PubMed ID: 29599478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicotinamide Riboside and Dihydronicotinic Acid Riboside Synergistically Increase Intracellular NAD
    Ciarlo E; Joffraud M; Hayat F; Giner MP; Giroud-Gerbetant J; Sanchez-Garcia JL; Rumpler M; Moco S; Migaud ME; Cantó C
    Nutrients; 2022 Jul; 14(13):. PubMed ID: 35807932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.